Počet záznamov: 1
moxisylyt
SYS d013948 LBL 00000nx--j22000003--45-- 005 20240119201218.3 100 $a 19990101csloy0103----ba0 152 $b mesh 250 $a moxisylyt $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 93; was THYMOXAMINE 1972-92 (Prov 1972); MOXISYLYTE was see THYMOXAMINE 1976-92 $8 eng 300 1-
$a Carvacrol (1966-1971) $8 eng 300 1-
$a Sympatholytics (1966-1971) $8 eng 330 1-
$a An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312) $8 eng 450 $a Thymoxamine $5 e $8 eng 450 $a Thymoxyalcylamine $5 e $8 eng 450 $a tymoxamín $5 e $8 slo 450 $a tymoxyalkylamín $5 e $8 slo 450 $a acetoxytymoxamín $5 e $8 slo 550 $3 sllk_un_auth*d000317 $Y Adrenergic alpha-Antagonists $5 P $a antagonisty alfa-adrenergických receptorov 550 $3 sllk_un_auth*d008916 $Y Miotics $5 P $a miotiká 550 $3 sllk_un_auth*d013565 $Y Sympatholytics $5 P $a sympatolytiká 550 $3 sllk_un_auth*d014665 $Y Vasodilator Agents $5 P $a látky vazodilatačné 686 $a D02.092.668.387.500 750 $a Moxisylyte $8 eng 801 -0
$a US $b DNLM $c 19990101 801 -2
$a SK $b BA006 $c 19991001 980 $x M
Počet záznamov: 1